» Articles » PMID: 35205796

Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Feb 25
PMID 35205796
Authors
Affiliations
Soon will be listed here.
Abstract

Hairy cell leukemia (HCL) is characterized by abnormal villous lymphoid cells that express CD103, CD123, CD25 and CD11c. HCL-like disorders, including hairy cell leukemia variant (vHCL) and splenic diffuse red pulp lymphoma (SDRPL), have similar morphologic criteria and a distinct phenotypic and genetic profile. We investigated the immunophenotypic features of a large cohort of 82 patients: 68 classical HCL, 5 vHCL/SDRPL and 9 HCL-like NOS. The HCL immunophenotype was heterogeneous: positive CD5 expression in 7/68 (10%), CD10 in 12/68 (18%), CD38 in 24/67 (36%), CD23 in 22/68 (32%) and CD43 in 19/65 (31%) patients. CD26 was expressed in 35/36 (97%) of HCL patients, none of vHCL/SDRPL and one of seven HCL-like NOS (14%). When adding CD26 to the immunologic HCL scoring system (one point for CD103, CD123, CD25, CD11c and CD26), the specificity was improved, increasing from 78.6% to 100%. We used unsupervised analysis of flow cytometry raw data (median fluorescence, percentage of expression) and the mutational profile of and . The analysis showed good separation between HCL and vHCL/SDRPL. The HCL score is not sufficient, and the use of unsupervised analysis could be promising to achieve a distinction between HCL and HCL-like disorders. However, these preliminary results have to be confirmed in a further study with a higher number of patients.

Citing Articles

Splenic B-cell Lymphoma / Leukemia with Prominent Nucleoli.

Gupta L, Chopra A Indian J Hematol Blood Transfus. 2025; 41(1):213-214.

PMID: 39917512 PMC: 11794748. DOI: 10.1007/s12288-024-01795-x.


Pure Biclonal Hairy Cell Leukemia-Apt Diagnosis with Multicolor Flow Cytometry.

Adnan S, Farrukh S, Ahmed A, Shaikh M Int J Hematol Oncol Stem Cell Res. 2024; 18(4):400-402.

PMID: 39703470 PMC: 11652695. DOI: 10.18502/ijhoscr.v18i4.16764.


Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group.

Paillassa J, Maitre E, Belarbi Boudjerra N, Madani A, Benlakhal R, Matthes T Cancers (Basel). 2024; 16(12).

PMID: 38927891 PMC: 11201647. DOI: 10.3390/cancers16122185.


Hairy cell leukemia - etiopathogenesis, diagnosis and modern therapeutic approach.

Mackowiak K, Jankowiak M, Szewczyk-Golec K, Holynska-Iwan I Biochem Med (Zagreb). 2024; 34(2):020502.

PMID: 38882583 PMC: 11177658. DOI: 10.11613/BM.2024.020502.


Untangling hairy cell leukaemia (HCL) variant and other HCL-like disorders: Diagnosis and treatment.

Troussard X, Maitre E J Cell Mol Med. 2023; 28(3):e18060.

PMID: 38095234 PMC: 10844692. DOI: 10.1111/jcmm.18060.


References
1.
Cro L, Morabito F, Zucal N, Fabris S, Lionetti M, Cutrona G . CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL. Hematol Oncol. 2009; 27(3):140-7. DOI: 10.1002/hon.888. View

2.
Angelova E, Medeiros L, Wang W, Muzzafar T, Lu X, Khoury J . Clinicopathologic and molecular features in hairy cell leukemia-variant: single institutional experience. Mod Pathol. 2018; 31(11):1717-1732. DOI: 10.1038/s41379-018-0093-8. View

3.
Forconi F, Sozzi E, Cencini E, Zaja F, Intermesoli T, Stelitano C . Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior. Blood. 2009; 114(21):4696-702. DOI: 10.1182/blood-2009-03-212449. View

4.
Matutes E, Martinez-Trillos A, Campo E . Hairy cell leukaemia-variant: Disease features and treatment. Best Pract Res Clin Haematol. 2015; 28(4):253-63. DOI: 10.1016/j.beha.2015.09.002. View

5.
Waterfall J, Arons E, Walker R, Pineda M, Roth L, Killian J . High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias. Nat Genet. 2013; 46(1):8-10. PMC: 3905739. DOI: 10.1038/ng.2828. View